29 Nov 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Colchester-based medical technology firm EnXray is planning to make a move to Nottingham. Mr Ed Cappabianca, CEO, EnXray, is planning to shift his entire medical technology company. He is joined in the management team by chief scientific officer Dr Sergey Mitko, and chief technical officer Dr Yuri Udalov.
Mr Cappabianca is already working with manufacturing and regulatory partners in Nottingham and is tapping into attractive funding packages available in the city to support technology innovation.
EnXray is working with the University of Nottingham's new Precision Manufacturing Center. The company is making X-ray sterilization economically feasible and reliable enough to be used on-site by manufacturers. The technology generates low-energy X-rays which deliver sterilising energy only where it is needed, and in the correct dose.
Although Mr Cappabianca is based in BioCity, he believes MediCity will be attractive to healthcare firms that will need his technology. The benefits for medical device manufacturers include lower total and per unit costs, improved time to market, reduced stocks costs and individual product sterilization which allows for 100 percent traceability.
Mr Cappabianca said: "We also see the logistics hub of East Midlands Airport as a way to access international markets for our technology from an early stage."